Ocular hypertension and corneal thickness: A long-term prospective study. Results after two years

European Journal of Ophthalmology

Volumn 15, Issue 5, 2005, Pages 550-555

  Brusini, Paolo ^a   Tosoni, C ^a   Parisi, L ^a   Rizzi, L ^b  

^a SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

Central corneal thickness; Frequency doubling technology; Non conventional visual field examination; Ocular hypertension

Indexed keywords

IBOPAMINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORNEA; EVALUATION; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NERVE FIBER; PERIMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; THICKNESS; ULTRASOUND; VISUAL FIELD;

EID: 26444560573     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500505     Document Type: Article

References (24)

1. Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol 1975; 53: 34-43.
2. Wolfs RCW, Klaver CCW, Vingerling JR, Grobbees DE, Hofman A, de Jong PT. Distribution of central corneal thickness and its association with intraocular pressure: The Rotterdam Study. Am J Ophthalmol 1997; 123: 767-72.
3. Herndon LW, Choudhri SA, Cox T, Damij KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol 1997; 115: 1137-41.
4. Bron AM, Creuzot-Garcher C, Goudeau-Boutillon S, d'Athis P. Falsely elevated intraocular pressure due to increased central corneal thickness. Graefes Arch Clin Exp Ophthalmol 1999; 3: 220-4.
5. Brusini P, Miani F, Tosoni C. Corneal thickness in glaucoma: an important parameter? Acta Ophthalmol Scand 2000; 78 (Suppl): S41-2.
6. Brandt JD, Beiser JA, Kass MA, Gordon MA. Corneal thickness in the Ocular Hypertension Treatment Study (OHTS). Ophthalmology 2001; 108: 1779-88.
7. Damji KF, Muni RH, Munger RM. Influence of corneal variables on accuracy of intraocular pressure measurement. J Glaucoma 2003; 12: 69-80.
8. Copt R-P, Thomas R, Mermoud A. Corneal thickness in ocular hypertension, primary open-angle glaucoma, and normal tension glaucoma. Arch Ophthalmol 1999; 117: 14-6.
9. Hodapp E, Parrish II RK, Anderson DR. Clinical Decisions in Glaucoma. St. Louis: Mosby, 1993; 46-7.
10. Quigley HA. Identification of glaucomatous visual field abnormality with the screening protocol of frequency-doubling perimetry. Am J Ophthalmol 1998; 125: 819-29.
11. Zhou Q, Weinreb RN. Individualized compensation of anterior segment birefringence during scanning laser polarimetry. Invest Ophthalmol Vis Sci 2002; 43: 2221-8.
12. Garway-Heath DF, Greaney MJ, Caprioli J. Correction for the erroneous compensation of anterior segment birefringence with the scanning laser polarimeter for glaucoma diagnosis. Invest Ophthalmol Vis Sci 2002; 43: 1465-74.
13. Zangwill L, Berry CA, Garden VS, Weinreb RN. Reproducibility of retardation measurements with the nerve fiber analyzer II. J Glaucoma 1997; 6: 384-9.
14. Waldock A, Potts MJ, Sparrow JM, Karwatowski SS. Clinical evaluation of scanning laser polarimetry: I. Intraoperator reproducibility and design of a blood vessel removal algorithm. Br J Ophthalmol 1998; 82: 252-9.
15. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol 2000; 44: 367-408.
16. Medeiros FA, Sample PA, Weinreb RN. Corneal thickness measurements and visual function abnormalities in ocular hypertensive patients. Am J Ophthalmol 2003; 136: 805-13.
17. Medeiros FA, Sample PA, Weinreb RN. Corneal thickness measurements and frequency doubling technology perimetry abnormalities in ocular hypertensive eyes. Ophthalmology 2003; 110: 1902-7.
18. Keltner JL, Johnson CA, Quigg JM, Cello KE, Kass MA, Gordon MO. Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Arch Ophthalmol 2000; 118: 1187-94.
19. Demirel S, Johnson CA. Incidence and prevalence of short wavelength automated perimetry deficits in ocular hypertensive patients. Am J Ophthalmol 2001; 131: 709-15.
20. Polo V, Larrosa JM, Pinilla I, Perez S, Gonzalvo F, Honrubia FM. Predictive value of short wavelength automated perimetry. A 3-year follow-up study. Ophthalmology 2002; 109: 761-5.
21. Virno M, Pecori Giraldi J, Taverniti L, Taloni M, Pannarale L. Intraocular hypertensive effects of topically administered ibopamine in eyes with hydrodynamic disorders: a new provocative test for glaucoma. Glaucoma 1990; 12: 88-92.
22. Virno M, Pecori-Girardi, Taverniti L, De Gregorio F, Sedran L. Ibopamine. D-1 Dopaminergic Agonist in the Physiopathology of Intraocular Pressure. Rome: I.N.C. Innovation-New-Communications Publ; 2003.
23. Gordon MO, Beiser JA, Brandt JD, et al, for the Ocular Hypertension Study Group. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open angle glaucoma. Arch Ophthalmol 2002; 120: 714-20.
24. Medeiros FA, Sample PA, Zangwill LM, Bowd C, Aihara M, Weinreb RN. Corneal thickness as a risk factor for visual field loss in patients with preperimetric glaucomatous optic neuropathy. Am J Ophthalmol 2003; 135: 131-7.